References
- Gonda I. Systemic delivery of drugs to humans via inhalation. J Aerosol Med. 2006;19:47–53.
- Hussain A, Arnold JJ, Khan MA, et al. Absorption enhancers in pulmonary protein delivery. J Control Release. 2004;94:15–24.
- Davis SS, Illum L. Absorption enhancers for nasal drug delivery. Clin Pharmacokinet. 2003;42:1107–1128.
- Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev. 2001;5:117–126.
- Seki T, Fukushi N, Chono S, et al. Effects of sperminated polymers on the pulmonary absorption of insulin. J Control Release. 2008;125:246–251.
- Morimoto K, Fukushi N, Chono S, et al. Spermined dextran, a cationized polymer, as absorption enhancer for pulmonary application of peptide drugs. Pharmazie. 2008;63:180–184.
- Marttin E, Verhoef JC, Romeijin SG, et al. Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity. Pharm Res. 1995;12:1151–1157.
- Merkus FWHM, Schiepper NGM, Hermens WAJJ, et al. Absorption enhancers in nasal drug delivery: efficacy and safety. J Control Release. 1993;24:201–208.
- Chono S, Fukuchi R, Seki T, et al. Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery. J Control Release. 2009;137:104–109.
- Kobayashi S, Kondo S, Juni K. Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancers. Pharm Res. 1994;11:1239–1243.
- Kobayashi S, Kondo S, Juni K. Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats. Pharm Res. 1996;13:80–83.
- Codrons V, Vanderbist F, Ucakar B, et al. Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs. J Pharm Sci. 2004;93:1241–1252.
- Huang YY, Wang CH. Pulmonary delivery of insulin by liposomal carriers. J Control Release. 2006;113:9–14.
- Liu FY, Shao Z, Kildsig DO, et al. Pulmonary delivery of free and liposomal insulin. Pharm Res. 1993;10:228–232.
- Florea BI, Cassara ML, Junginger HE, et al. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Release. 2003;87:131–138.
- Afrezza [Internet]. MannKind Corporation: Danbury, CT. 2017 [March]. Prescribing information. Available from: http://www.afrezza.com/wp-content/uploads/2016/08/afrezza.pdf
- Poelma DL, Zimmermann LJ, van Cappellen WA, et al. Distinct effects of SP-B and SP-C on the uptake of surfactant-like liposomes by alveolar cells in vivo and in vitro. Am J Physiol Lung Cell Mol Physiol. 2004;287:1056–1065.
- Chono S, Tanino T, Seki T, et al. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for the treatment of respiratory intracellular parasitic infections. J Control Release. 2008;127:50–58.
- Chono S, Kaneko K, Yamamoto E, et al. Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages. Drug Dev Ind Pharm. 2010;36:102–107.
- Chono S, Suzuki H, Togami K, et al. Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections. Drug Dev Ind Pharm. 2011;37:367–372.
- Kaneko K, Togami K, Yamamoto E, et al. Sustained distribution of aerosolized PEGylated liposomes in epithelial lining fluid on alveolus surface. Drug Deliv and Transl Res. 2016;6:565–571.